What is Protagonist Therapeutics's investment purchases?

Protagonist Therapeutics (PTGX) reported investment purchases of $68.97M in Q1 2026.

How has Protagonist Therapeutics's investment purchases changed year-over-year?

Protagonist Therapeutics's investment purchases decreased by 67.8% year-over-year, from $214.04M to $68.97M.

What is the long-term trend for Protagonist Therapeutics's investment purchases?

Over 4 years (2021 to 2025), Protagonist Therapeutics's investment purchases has grown at a 17.5% compound annual growth rate (CAGR), from $286.59M to $546.59M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

Protagonist Therapeutics PTGX Investment Purchases

Investment Purchases at other companies

Eli LillyLLY

$297M+50.8%

Spyre Therapeutics, Inc.SYRE

$81.17M+13.6%

ImmunityBio, Inc.IBRX

$139.09M+138,993%

Arrowhead ResearchARWR

$924.64M+43.5%

Summit TherapeuticsSMMT

$177.29M—

Kymera TherapeuticsKYMR

——

Other financials

Income statement

See full

Revenue$56.4M+99.0%

Operating income-$3.6M+81.1%

Net income$3.8M+132%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$193.7M+38.7%

Total debt$9.8M-13.9%

Total equity$655.5M-4.9%

Total assets$697.5M-6.0%

Cash flow

See full

Operating cash flow-$48.9M-139%

CapEx$215.0K-60.6%

Free cash flow-$49.2M-139%

Valuation

See full

Market cap$7.26B+127%

Enterprise value$7.07B+130%

P/S98×+82.6×

Profitability

See full

Operating margin-192.4%-205pp

Net margin-154.9%-182pp

FCF margin-12,264.3%-12,527pp

Returns & leverage

See full

Return on equity-17.1%-26.1pp

Debt / equity0×0.0×

Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Protagonist Therapeutics's investment purchases?: Protagonist Therapeutics (PTGX) reported investment purchases of $68.97M in Q1 2026.
How has Protagonist Therapeutics's investment purchases changed year-over-year?: Protagonist Therapeutics's investment purchases decreased by 67.8% year-over-year, from $214.04M to $68.97M.
What is the long-term trend for Protagonist Therapeutics's investment purchases?: Over 4 years (2021 to 2025), Protagonist Therapeutics's investment purchases has grown at a 17.5% compound annual growth rate (CAGR), from $286.59M to $546.59M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.